Cardinal Health

Preventing Venous Thromboembolism: A Healthcare Professional Guide to Intervention 26 References. 1. Hill SL, Holtzman GI, Martin D, Evans P, Toler W, Goad K. The Origin of Lower Extremity Deep Vein Thrombi in Acute Venous Thrombosis. American Journal of Surgery 1997; 173: 485-490. 2. O’Meara PM, Kaufman EE. Prophylaxis for Venous Thromboembolism in Total Hip Arthroplasty: A Review. Orthopaedics 1990; 13: 173-178. 3. James AH. Venous Thromboembolism in Pregnancy. Arterioscler. Thromb. Vasc. Biol. 2009; 29 (3): 326-331. 4. Chan WL, Spencer FA, Ginsbergm JS. Anatomic distribution of deep vein thrombosis in pregnancy. CMAJ 2010; 182 (7):657-660. 5. Venous Thromboembolism Prevention Clinical Care Standard, January 2020. The Australian Commission on Safety and Quality in Health Care. https://www.safetyandquality.gov.au/publications-and-resources/ resource-library/venous-thromboembolism-prevention-clinical-care- standard 6. Access Economics Pty Ltd for the Australia and New Zealand working party on the management and prevention of venous thromboembolism. The burden of venous thromboembolism in Australia, 1 May 2008. Access Economics Pty Ltd; 2008; Available from: https://www.safetyandquality.gov.au/sites/default/files/migrated/ Access-Economics_The-burden-of-VTE-in-Australia_2008.pdf. 7. Australia and New Zealand Working Party on the Management and Prevention of Venous Thromboembolism. Prevention of venous thromboembolism best practice guidelines for Australia and New Zealand. 4. Sydney, Health Education and Management Innovations; 2007. 8. National Health and Medical Research Council. Clinical practice guideline for the prevention of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to Australian hospitals. Melbourne, National Health and Medical Research Council; 2009. 9. White R. The epidemiology of venous thromboembolism. Circulation 2003; 107 (23)(supl 1): 14-8. 10. James AH. Pregnancy-associated thrombosis. American Society of Hematology . 2009; 277–285. 11. Geerts, W. Bergqvist, D. Pineo, G. Heit, J. Samama, C. Lassen, and M. Colwell. Prevention of venous thromboembolism: The American College of Chest Physicians Evidence based clinical practice guidelines eighth edition. Chest 2008; 133: 381S-453S 12. The Stroke Foundation: Clinical Guidelines for Stroke Management https://strokefoundation.org.au/ 13. Saab J, Salvatore SP. Evaluating the Cause of Death in Obese Individuals: A Ten-Year Medical Autopsy Study. Journal of Obesity 2015; 1-7. 14. Ageno W, Squizzato A, Garcia D, Imberti D. Epidemiology and Risk Factors of Venous Thromboembolism; Seminars in Thrombosis and Hemostasis . 2006; 32(7):651-8 15. Breddin H, Carpentier P, Coccheri S, Defano V, Elkoofy, Gerotziafas G., et al. Thrombophilia and venous thromboembolism: International Consensus Statement under the auspices of the European Genetics foundation, the Cardiovascular Disease Educational and Research Trust. The International Union of Angiology and the Mediterranean League on Thromboembolism.2004; September 5, 1-56. 16. Heit JA, Spencer FA, White RH.The epidemiology of venous thromboembolism Journal of Thrombosis and Thrombolysis (2016) 41:3–14 17. Rosendaal, F. Risk factors for venous thrombosis: prevalence, risk and interaction. Seminars in Haematology , 1997; 34(3), 171-187. 18. Bulger, C, Jacobs, C. Patel, N. Epidemiology of acute deep vein thrombosis. Techniques in Vascular and Interventional Radiology, 2004; 7(2), 50-54. 19. Farge D, Frere C, Connors JM, et al. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol . 2019;20(10):e566–e581. doi:10.1016/S1470-2045(19)30336-5 20. International Consensus Statement, Guidelines according to scientific evidence. Edition 2006. 21. Queensland Clinical Guidelines. Venous thromboembolism (VTE) in pregnancy and the puerperium. Guideline MN20.9-V6-R25. Queensland Health. 2020. Available from: http://www.health.qld.gov.au/qcg 22. Ageno W, Becattini C, Brighton T, Selby R, and Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a metaanalysis. Circulation 2008; 117 (1) 93–102. 23. Cohen AT, Tapson VF, Bergmann JF, Goldhaber ST et al. Venous Thromboembolism Risk and Prophylaxis in the Acute Hospital Care Setting (ENDORSE study): A Multinational Cross-Sectional Study The Lancet 2008:371: 387–94. 24. Nicolaides AN, et al. A rational approach to prevention. Thromboembolism, aetiology, advances in prevention and management. Lancaster, Medical and Technical publishing 1975. 25. Kelly J, Rudd A, Lewis RR, Hunt BJ. Screening for subclinical deep‐vein thrombosis. QJM: An International Journal of Medicine 2001; 94 (10):511–519. 26. Nicolaides AN, Fareed J, Kakkar AK, et al. Prevention and treatment of venous thromboembolism – International Consensus Statement. Int Angiol . 2013;32(2):111–260. 27. Michota F. Prevention of thromboembolic events. Clinical Cornerstone. 2005; (7) 4: 8-15. 28. Vormfelde SV, Abu Abed M, Hua TD, Schneider S, Friede T, C henot JF: Educating orally anticoagulated patients in drug safety—a cluster randomized study in general practice. Dtsch Arztebl Int 2014; 111: 607–14. 29. Hogg K, Kimpton M, Carrier M, Coyle D, Forgie M, Wells P. Estimating Quality of Life in Acute Venous Thrombosis. JAMA InternMed. 2013;173(12):1067–1072. 30. Kahn SR, Shbaklo DL, Lamping CA, Holcroft I et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. Journal of Thrombosis and Haemostasis 2008; 6:1105-1112 31. Pengo V, Lensing AW, Prins MH, et al. Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. New England Journal of Medicine 2004; 350: 2257-64. 32. Heparin Sodium Product Information 33. Enoxaparin/Dalteparin Product Information 34. Fondaparinux Product Information 35. Rivaroxaban Product Information 36. Dabigatran Product Information. https://www.tga.gov.au/sites/default/ files/auspar-dabigatran-etexilate-pi-160104.pdf 37. Apixaban Product Information 38. Warfarin Product Information 39. Wells PS, Lensing AWA, Hirsh J. Graduated Compression Stockings in the Prevention of Postoperative Venous Thromboembolism. Arch InternMed . 1994;154:67-71. 40. Coleridge-Smith PD, et al. Deep Vein Thrombosis: Effect of Graduated Compression Stockings on Distension of the Deep Veins of the Calf. British Journal of Surgery . June 1991. Vol 78, No. (6): 724-726. 41. Sigel B, Edelstein A, Savitch L, Hasty J, Felix R. Type of Compression for Reducing Venous Stasis. Archives of Surgery . 1975; 110: 171-175. 42. Kakkos SK, Szendro G, Griffin M, Daskalopoulou S, Nicholaides AN. The efficacy of the new SCD response compression system in the prevention of venous stasis. Journal of Vascular Surgery 2000; 32 (5):932-40. 43. Dennis, M, et al. Thigh Length versus below-knee stockings for Deep Venous Thrombosis prophylaxis after stroke. Ann InternMed . 2010; 153:553-562. 44. Nicholaides AN, Fernandes e Fernandes J, Pollack AV. Intermittent sequential pneumatic compression of the legs in the prevention of venous stasis and postoperative deep vein thrombosis. Surgery 1980; 87: 69-76. 45. Comerota AJ, Chouhan VS, Harada RN, Sun L, Hosking J, Veermansunemi R, Schlappy D, Rao AK. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Annals of Surgery 1997; 226 (3):306-13 46. Gardner AMN, Fox RH. The return of blood to the heart. John Libbey and Co., London, Second Edition 1993 47. Morgan R, Carolan G, Psaila J, Gardner A, Fox R, Woodcock J. Arterial flow enhancement by impulse compression. Vascular Surgery . 1991;25(1):8-16.